4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-025971
Acting Chief Business Officer sold 40,000 shares at an average $13.33 ($533,304)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…